Corteva, Inc. (CTVA) stock analysis
Basic Materials · Agricultural Inputs
From the 10-K filed 2026-02-12
Business type: Franchise
How it makes money
Corteva earns revenue by selling seeds and crop protection products to farmers across approximately 110 countries worldwide.
Corteva operates through two main segments: Seed and Crop Protection. The Seed segment develops and supplies commercial seed combining superior germplasm with advanced traits to produce high yield potential for farmers around the world. The Crop Protection segment supplies products to protect crop yields against weeds, insects and disease, enabling farmers to achieve optimal results.
Sales are driven by farmers' ongoing needs to boost productivity amid growing populations, natural resistance, and changing weather patterns. The company relies on its routes to market to work face-to-face with growers globally.
What protects it: the moat
Corteva protects its position through extensive research and development pipelines and proprietary germplasm and biotechnology traits.
Management states that the company leverages its rich heritage of scientific achievement to advance its robust innovation pipeline and continue to shape the future of responsible agriculture. It maintains proprietary positions in North America corn and soybeans, Europe corn and sunflower, as well as Brazil, India, South Africa and Argentina corn.
However, management notes that these advantages depend heavily on securing and maintaining complex regulatory approvals for new biotechnology traits and active ingredients across multiple global jurisdictions.
What growth costs
The filing does not disclose specific aggregate figures for the ongoing capital expenditures or research and development costs required to grow earnings.
The company engages in extensive testing, advanced breeding technologies, and active ingredient discovery to develop pipeline products. Management notes that these processes involve significant costs and capital expenditures, but the text omits specific financial figures for these investments.
What could damage it
A failure to obtain or maintain necessary regulatory approvals could restrict product sales in key markets and impair earnings.
Regulatory requirements govern the development, manufacture, and distribution of seeds and crop protection products. If Corteva fails to secure timely approvals, or if existing approvals are invalidated through lawsuits or changing standards, the company cannot commercialize its pipeline. This disruption prevents the monetization of research and development investments and directly reduces profitability.
About Corteva, Inc.
Corteva, Inc. operates as a pure-play agriculture company in the United States, Canada, the Middle East, Africa, Europe, Latin America, and Asia. The company provides products that protect against weeds, insects, diseases, nematodes, and other pests, as well as supports crop health via nitrogen management and seed-applied technologies. Its crop protection solutions and digital solutions provide farmers tools to improve productivity and help keep fields free of weeds, insects, and diseases. The company offers herbicides, soybeans, cereals, fruits and vegetables, insecticides, nitrogen stabilizers, pasture, and a range management herbicides and biologicals and other nature-based products. The company was incorporated in 2018 and is headquartered in Indianapolis, Indiana.